CAH Cardinal Health, Inc.
USHealthcareAs of 2026-07-08 16:00
Why CAH matters now
Cardinal Health, Inc. (CAH) is a US stock in Healthcare. The latest InvestLog snapshot shows $237.15 with -1.07% on the session and $55.54B in market capitalization; recent performance reads 1-month +10.68% and YTD +7.92%.
The latest financial table shown here is Q3 2026, with revenue of $60.94B, net income of $399.0M, and EPS of $1.69. Investors can compare that operating picture with valuation signals such as P/E 30.44 and FCF yield 8.5%.
The latest indexable market news headline is "Cardinal Health (CAH) Declines More Than Market: Some Information for Investors" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $255.50; recent insider activity includes Hall Patricia Hemingway filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
30.44
PEG
1.13
P/B
-18.40
P/S
0.21
EV/EBITDA
18.81
DCF Value
$350.82
FCF Yield
8.5%
Div Yield
0.9%
Margins & Returns
Gross Margin
3.7%
Operating Margin
0.9%
Net Margin
0.6%
ROE
-55.7%
ROA
2.8%
ROIC
11.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $60.94B | $399.0M | $1.69 |
| Q2 2026 | $65.44B | $471.0M | $1.97 |
| Q1 2026 | $64.01B | $450.0M | $1.88 |
| Q4 2025 | $60.16B | $239.0M | $1.00 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$253.38
Target (Median)
$255.50
Target Range
$235.00 - $275.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Distribution
Country
US
Exchange
—
Beta
0.53
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.